XML 96 R45.htm IDEA: XBRL DOCUMENT v3.25.0.1

Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Compensation [Abstract]

Schedule of Company Granted Options

In the years ended December 31, 2024, and 2023, the Company granted options as follows:

Year ended December 31, 2024

Award amount

Exercise price

Vesting period

Expiration

Employees

65,957

0.23 NIS

4 years

10 years

Employees

378,901

$9.44-$10.88

4 years

10 years

Directors

75,957

0.23 NIS

4 years

10 years

Subcontractors

4,390

0.23 NIS

4 years

10 years

Subcontractors

16,834

$9.67-$10.48

4 years

10 years

Total granted

542,039

Year ended December 31, 2023

Award amount

Exercise price

Vesting period

Expiration

Employees

339,185

0.23 NIS

4 years

10 years

Subcontractors and directors

4,997

0.23 NIS

4 years

10 years

Total granted

344,182

Schedule of Fair Value of the Options

The underlying data used for computing the fair value of the options (as of the grant date) are as follows:

		2024				2023
Employees
Expected term (years) —			6.11				5.91-6.14
Expected volatility			43.48	%			40.98% - 42.14	%
Risk free interest rate			4.30	%			3.80%-3.83	%
Expected dividend yield			0.00	%			0.00	%
Exercise price			0.06-10.48				0.06
Non-Employees
Expected term (years) —			10.00				10.00
Expected volatility			43.48	%			42.09%-42.17	%
Risk free interest rate			4.30	%			3.64%-3.75	%
Expected dividend yield			0.00	%			0.00	%
Exercise price			0.06-10.48				0.06
Assumptions regarding the price of the underlying shares:
Probability of an IPO			30	%			25	%
Expected time to IPO (years)			0.5				0.75
Probability of liquidation event			70	%			75	%
Expected time to liquidation (years)			2.0				2.0

Schedule of Outstanding and Exercisable Options

The following table summarizes the number of options outstanding for the years ended December 31, 2024 and December 31, 2023, and related information:

		Number of options				Weighted- average exercise price				Weighted- average remaining contractual term (in years)				Aggregate Intrinsic Value (in U.S. dollars)
Outstanding at December 31, 2023			1,300,475			$	0.066				7.75			$	14,109
Granted			542,039			$	7.667				9.85			$	-
Exercised			(186,038	)		$	0.062				(6.82	)		$	1,508
Forfeited			(23,684	)		$	4.466				(8.86	)		$	-
Expired			(2,219	)		$	0.065							$	-
Outstanding at December 31, 2024			1,630,573			$	2.5259				7.63			$	12,274
Exercisable at December 31, 2024			947,700			$	0.518				6.67			$	8,938
Vested and expected to vest at December 31, 2024			1,630,573			$	2.529				7.63			$	12,274

		Number of options				Weighted- average exercise price				Weighted- average remaining contractual term (in years)				Aggregate Intrinsic Value (in U.S. dollars)
Outstanding at December 31, 2022			1,008,927			$	0.068				8.12			$	9,601
Granted			344,182			$	0.063				9.80			$	-
Exercised			(23,254	)		$	0.062				(7.10	)		$	224
Forfeited			(24,374	)		$	0.067				(8.91	)		$	-
Expired			(5,006	)		$	0.070				-			$	-
Outstanding at December 31, 2023			1,300,475			$	0.066				7.75			$	14,109
Exercisable at December 31, 2023			818,625			$	0.067				7.28			$	8,881
Vested and expected to vest at December 31, 2023			1,300,475			$	0.066				7.75			$	14,109

Schedule of Company’s Nonvested Employee Options

The following table summarizes the number of options outstanding for the years ended December 31, 2024 and December 31, 2023, and related information:

		Number of options				Weighted- average grant-date fair value price
Outstanding at December 31, 2023			481,850				9.68
Granted			542,039				13.25
Vested			(317,304	)			9.99
Forfeited			(23,684	)			10.83
Outstanding at December 31, 2024			682,901				12.33
Outstanding at December 31, 2022			458,218				8.24
Granted			344,182				10.80
Vested			(296,176	)			8.76
Forfeited			(24,374	)			9.53
Outstanding at December 31, 2023			481,850				9.68

Schedule of Consolidated Statements of Operations

The share-based compensation expense by line item in the accompanying consolidated statements of operations is summarized as follows:

		Year ended December 31
		2024				2023
Cost of sales		$	303			$	139
Research and development			610				240
General and administrative			4,975				1,964
Sales and marketing			719				224
		$	6,607			$	2,567

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(1)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding performance-based awards that are fully vested and expected to vest. Includes, but is not limited to, unvested awards for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(1)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardPerformanceBasedUnitsVestedAndExpectedToVestTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration